Healthy Volunteers Clinical Trial
Official title:
Acute Effects of Energy Drink on Hemodynamic and Electrophysiologic Parameters in Habitual and Non-Habitual Caffeine Consumers
The consumption of energy drinks has significantly increased in recent years but their
adverse effects are not yet efficiently known. The objective of the study is to determine the
acute effects of energy drink on habitual and non-habitual caffeine consumers and if caffeine
consumption habit causes a difference on the hemodynamic and electrophysiologic parameters.
This study was conducted on 48 students selected from Aydın Adnan Menderes University. Four
main groups were determined according to the results of the application acceptance survey.
Blood pressure, electrocardiogram, breath rate, haemoglobin oxygen saturation and
bioelectrical impedance analysis were measured before consuming the drinks. After consuming
the drinks, measurements were repeated at 30 minutes and 60 minutes. In addition to this,
Participant's Situation Anxiety Scale was applied.
In this study, it is aimed to determine the acute effects of energy drink on habitual and
non-habitual caffeine consumers and if caffeine consumption habit causes a difference on the
hemodynamic and electrophysiologic parameters. In this respect, the complicated human body's
reactions to these beverages will be examined in more detail.
Materials and methods Participants Forty eight participants (16 female, 32 male) aged 18-24
were selected from the students which are in the first year of various faculties of Aydın
Adnan Menderes University. The individuals were identified by collecting the age, weight,
height, BMI, caffeine and energy drink consumption habit information by applicant acceptance
questionnaire. According to the results of applicant acceptance questionnaire, those with a
body mass index greater than 30 kg/m2, a systemic disease, current alcoholism and smokers
were not included in the study. Also, the participants who has previous adverse reactions to
energy drinks were excluded to prevent undesired reactions associated with this condition.
Based on the applicant acceptance questionnaire 12 subjects were low-habitual caffeine
consumers with an estimated daily intake of approximately 130 mg caffeine and named as energy
drink 2 (ED2) group, 12 subjects were high-habitual caffeine consumers with an estimated
daily intake of approximately more than 200 mg caffeine and named as energy drink 3 (ED3)
group, while 24 subjects were caffeine naive (energy drink 1 (ED1) (n=12) and Control (n=12))
. This study conforms to the Declaration of Helsinki and was approved by the Institutional
Medical Ethics Committee of Adnan Menderes University (Protocol number: 2017/1211).
Experimental protocol All experiments were performed in a quiet and isolated room from
external factors with room temperature of about 20°C and relative humidity between %40 and
60. All participants were advised to avoid alcohol and caffeine containing foods for at least
72 h prior to the test and to come with an overnight (12 h) fasting.
Blood pressure, electrocardiogram, breath rate, haemoglobin oxygen saturation (HOS) and BIA
measurements were performed from the participants before the consumption of drinks. After the
measurements ED1, ED2 and ED3 groups consumed 473 ml of Red Bull energy drink containing
151.36 mg caffeine and control group consumed the same amount of water within 5 minutes. The
measurements were performed again in 30 minutes and 60 minutes. Also, state-trait anxiety
inventory test (STAI) was used to assess the physiological stress of the participants.
Blood Pressure Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured
indirectly by using a stethoscope (Littman Classic II, Saint Paul, USA) and aneroid
sphygmomanometer (Welch Allyn Tycos, New York, USA) on each participant left arm in sitting
position.
Electrocardiography (ECG) After a 5 min resting in the sitting position ECG recordings were
obtained from all the individuals for 5 min in rest. Disposable Ag-AgCl electrodes were
placed following the Einthoven triangle configuration. ECG measurement was performed with
sampling frequency 200 Hz using ECG100C unit and BIOPAC Acqknowledge acquisition software
(Biopac System Inc., Santa Barbara, CA) connected to a personal computer. PR interval, QRS
complex and QTc interval values were determined from ECG recordings of the participants. QTc
was calculated by Bazett's formula (QTc=QT/RR). Their normal range values are 120-200 ms,
normal<140 ms and normal < 400 ms, respectively.
For acquiring the heart rate variability (HRV) time series, Pan and Thompkins algorithm was
used. R peaks were detected and R-R intervals are defined. The time duration between two
consecutive R peaks is termed as RR interval (tRR). The sample size of the HRV time series is
400. The heart rate (HR) is determined as:
HR=60/t_RR State-trait Anxiety Inventory (STAI) It is a test developed to determine the
psychological stress during the study. STAI is defined as state and trait anxiety scale. This
test is composed of two parts (40 questions). State Anxiety scale consisting of the first 20
questions was used to obtain information about the acute anxiety state of participants at the
time of the study. Each question is evaluated using an ordinal scale (not at all=1,
somewhat=2, moderately=3, very much=4). The total score is obtained as the sum of each answer
value and gives information about the anxiety state of the participant. A total score of 50
or more is considered as positive pathological anxiety.
Haemoglobin Oxygen Saturation (HOS) HOS was measured by using a fingertip pulse oximeter on
the second left finger for 1 min.
Breath Rate Breath rate measurements were taken from the participants by counting the breaths
for one minute with the use of a stethoscope (Littman Classic II, Saint Paul, USA).
Bioelectrical Impedance Analysis (BIA) BIA measurements were taken by using In Body 720
before the consumption of the drinks and at 60th minute after the consumption. Each
participant was asked to stand on the body composition analyzer after undressing their
clothes. In Body 720 has an eight-point tactile electrode system that separately measures the
impedance of the arms, trunk and legs. It measures directly the amount of the intracellular
water (ICW), extracellular water (ECW), body fat percentage (PBF), body mass index (BMI) and
body metabolism rate (BMR).
Statistical analysis Statistical analysis of the data was performed by using SPSS Statistics
for Windows, Version 14.0. (SPSS Inc., Chicago, Illinois, USA). For comparing the groups
first of all Shapiro-Wilk (SW) normality test was applied to determine the normality of the
distribution. If the result of (SW) normality test was bigger than 0.05 the data were
normally distributed and were analysed by using one-way analysis of variance (ANOVA) with
Bonferroni post-test but if the result was less than 0.05 the data were not normally
distributed and were analysed by using Kruskal-Wallis non-parametric test. Repeated ANOVA
test was used for the comparison of different measurement time data of the same group.
Descriptive statistics were presented as mean ± standard error of the mean (SEM). A p-value
of less than 0.05 was considered to indicate statistical significance.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |